awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q40485092-6834C9D6-ACAC-4C69-A814-90BD6037302B
Q40485092-6834C9D6-ACAC-4C69-A814-90BD6037302B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40485092-6834C9D6-ACAC-4C69-A814-90BD6037302B
Safety, efficacy, and pharmacokinetics of navitoclax (ABT-263) in combination with erlotinib in patients with advanced solid tumors.
P2860
Q40485092-6834C9D6-ACAC-4C69-A814-90BD6037302B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40485092-6834C9D6-ACAC-4C69-A814-90BD6037302B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6b7b096aeab63dc4f8b8daec09e97d8ba8bdea26
P2860
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group